PubMed Health⌕ Search

PubMed · 16857291

An integrative software package for gastrointestinal biomagnetic data acquisition and analysis using SQUID magnetometers.

Abstract

The study of bioelectric and biomagnetic activity in the human gastrointestinal (GI) tract is of great interest in clinical research due to the proven possibility to detect pathological conditions thereof from electric and magnetic field recordings. The magnetogastrogram (MGG) and magnetoenterogram (MENG) can be recorded using superconducting quantum interference device (SQUID) magnetometers, which are the most sensitive magnetic flux-to-voltage converters currently available. To address the urgent need for powerful acquisition and analysis software tools faced by many researchers and clinicians in this important area of investigation, an integrative and modular computer program was developed for the acquisition, processing and analysis of GI SQUID signals. In addition to a robust hardware implementation for efficient data acquisition, a number of signal processing and analysis modules were developed to serve in a variety of both clinical procedures and scientific investigations. Implemented software features include data processing and visualization, waterfall plots of signal frequency spectra as well as spatial maps of GI signal frequencies. Moreover, a software tool providing powerful 3D visualizations of GI signals was created using realistic models of the human torso and internal organs.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Andrei Irimia, Leo K Cheng, Martin L Buist, Andrew J Pullan, L Alan Bradshaw. 2006-07-18. An integrative software package for gastrointestinal biomagnetic data acquisition and analysis using SQUID magnetometers.. https://doi.org/10.1016/j.cmpb.2006.03.006

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Symptoms involving the gastrointestinal tract].

Symptoms involving the gastrointestinal tract are very common in patients who require palliative treatment. They can be caused by the patient's underlying (malignant) disease or by the treatment of this disease. Nausea and vomiting as well as constipation are of the utmost importance in this context due both to their frequency as well as their complex consequences. A careful evaluation of the patient's history combined with a few diagnostic procedures will help to provide a treatment which is orientated on pathophysiology.

Gastrointestinal Diseases↗

Serotonergic receptors in therapeutic approaches to gastrointestinal disorders.

Most of the cloned serotonin (5-HT) receptor subtypes are present on enteric neurons that control gastrointestinal function. Because of the wide distribution of 5-HT receptor subtypes in the gut, the precise actions of currently marketed drugs are unclear. Furthermore, efficacy of these drugs varies between individuals. Two recent advances provide important potential explanations for this phenomenon: polymorphisms have recently been discovered in the gene for the key enzyme in neural 5-HT production, and physiologically relevant 5-HT(4) receptor splice variants have been shown to be differentially located across intestinal regions. Functional 5-HT(7) receptors have recently been demonstrated in the gut and, together with the 5-HT(1A) receptor, offer new therapeutic options. In addition, recently suggested identities for the elusive 5-HT(1P) receptor could result in other, more effective therapeutic targets.

Gastrointestinal Diseases↗